Skip to main content

Table 1 Demographics of Patients and Control subjects

From: Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort

  ALL LRRK2 G2019S carriers
Patients Controls p-value Patients Controls
N 250 218   84 (33.6%) 3 (1.3%)
Sex ratio (Men:Women) 1.2 (136:114) 1.1 (112:106) 0.51 1.1 (44:40) 2 (2:1)
Mean age (years, SD) 65.8 (10.8) 62.2 (10.5) 0.34 64.1 (11.5) 55.3 (7.5)
Median age (years, IQR) 66 (59–75) 61.5 (53–71)   64 (57–74) 55 (48–63)
Mean age at onset (years, SD) 58.5 (12.3)   56.1 (12.7)
Median age at onset (years, IQR) 59 (49–67)   57 (46–65)